Summary
Zymeworks Inc. (Zymeworks) is a biotherapeutics company that develops antibody and protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases. The company also develops technologies in the area of biologics drug discovery and optimization. Zymeworks’ technology includes ZymeCAD, which is a protein engineering technology platform that develops antibody and antibody alternative products. It also provides other technology platforms such as Azymetric scaffold, AlbuCORE scaffold, EFECT platform, and HL.Max platform. The company caters to pharmaceutical and chemical markets. Zymeworks is headquartered in Vancouver, British Columbia, Canada.
Zymeworks Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Zymeworks Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Zymeworks Inc., Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Zymeworks Raises USD61.5 Million in Series A Financing 11
Zymeworks Raises USD4 Million in Venture Financing 14
Zymeworks Raises US$11 Million In Venture Financing 15
Zymeworks Secures Additional US$4 Million In Venture Financing 16
Zymeworks Secures US$8.1 Million In Financing 17
Zymeworks Secures US$3.1 Million In Venture Financing 18
Partnerships 19
ImClone Systems Extends Licensing Agreement with Zymeworks 19
Applied BioMath Partners with Zymeworks 20
Zymeworks Enters into Agreement with Kairos Therapeutics 21
ProBioGen Enters into Agreement with Zymeworks 22
Zymeworks Enters into Research Agreement with University of California, Los Angeles 23
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 24
Licensing Agreements 25
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 25
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 27
Zymeworks Enters into Licensing Agreement with Celgene for Bi-Specific Antibody 28
Zymeworks Extends Licensing Agreement with Merck 29
Zymeworks Enters Into Licensing Agreement With Merck 30
Equity Offering 31
Zymeworks Completes Private Placement of Shares for USD17.3 Million 31
Acquisition 32
Zymeworks Acquires Kairos Therapeutics 32
Zymeworks Inc. - Key Competitors 33
Key Employees 34
Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Zymeworks Inc., Pharmaceuticals & Healthcare, Key Facts 1
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Zymeworks Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Zymeworks Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Zymeworks Raises USD61.5 Million in Series A Financing 11
Zymeworks Raises USD4 Million in Venture Financing 14
Zymeworks Raises US$11 Million In Venture Financing 15
Zymeworks Secures Additional US$4 Million In Venture Financing 16
Zymeworks Secures US$8.1 Million In Financing 17
Zymeworks Secures US$3.1 Million In Venture Financing 18
ImClone Systems Extends Licensing Agreement with Zymeworks 19
Applied BioMath Partners with Zymeworks 20
Zymeworks Enters into Agreement with Kairos Therapeutics 21
ProBioGen Enters into Agreement with Zymeworks 22
Zymeworks Enters into Research Agreement with University of California, Los Angeles 23
National Research Council Enters into Co-Development Agreement with Zymeworks for Cancer 24
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 25
Zymeworks Enters into Licensing Agreement with GlaxoSmithKline 27
Zymeworks Enters into Licensing Agreement with Celgene for Bi-Specific Antibody 28
Zymeworks Extends Licensing Agreement with Merck 29
Zymeworks Enters Into Licensing Agreement With Merck 30
Zymeworks Completes Private Placement of Shares for USD17.3 Million 31
Zymeworks Acquires Kairos Therapeutics 32
Zymeworks Inc., Key Competitors 33
Zymeworks Inc., Key Employees 34
Zymeworks Inc., Other Locations 35
Zymeworks Inc., Subsidiaries 35
List of Figures
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Zymeworks Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
